The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).
Standard
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97). / Escherich, Gabriele; Troeger, Anja F; Gobel, Ulrich; Graubner, Ulrike; Pekrun, Arnulf; Jorch, Norbert; Kaspers, Gjl; Zimmermann, Martin; Zur Stadt, Udo; Kazemir, Karin; Pieters, Rob; Horstmann, Martin; Denboer, Monique L; Janka-Schaub, Gritta.
in: HAEMATOLOGICA, Jahrgang 96, Nr. 6, 6, 2011, S. 854-862.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).
AU - Escherich, Gabriele
AU - Troeger, Anja F
AU - Gobel, Ulrich
AU - Graubner, Ulrike
AU - Pekrun, Arnulf
AU - Jorch, Norbert
AU - Kaspers, Gjl
AU - Zimmermann, Martin
AU - Zur Stadt, Udo
AU - Kazemir, Karin
AU - Pieters, Rob
AU - Horstmann, Martin
AU - Denboer, Monique L
AU - Janka-Schaub, Gritta
PY - 2011
Y1 - 2011
N2 - In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients' cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment stratification. In parallel in vivo treatment response was assessed by determining the presence and extent of minimal residual disease in a subset of patients (n=224). Here we report the long-term impact of in vitro sensitivity-based risk stratification according to survival and compare the results of in vitro sensitivity with in vivo response.
AB - In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients' cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment stratification. In parallel in vivo treatment response was assessed by determining the presence and extent of minimal residual disease in a subset of patients (n=224). Here we report the long-term impact of in vitro sensitivity-based risk stratification according to survival and compare the results of in vitro sensitivity with in vivo response.
U2 - 10.3324/haematol.2010.039735
DO - 10.3324/haematol.2010.039735
M3 - SCORING: Journal article
VL - 96
SP - 854
EP - 862
JO - HAEMATOLOGICA
JF - HAEMATOLOGICA
SN - 0390-6078
IS - 6
M1 - 6
ER -